Invivyd's SPEAR Study Group will investigate PEMGARDA®'s efficacy in treating Long COVID and Post-Vaccination Syndrome through monoclonal antibody therapy. Invivyd, Inc. has established the SPEAR ...
Scientists from Harvard University and the Australian National Phenome Centre (Murdoch University) analysed blood samples from 147 children across different COVID-19 conditions and identified ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果